Dr. Florin Rader reviews the results of treatment with mavacamten from the EXPLORER-LTE cohort of the MAVA-LTE study in patients with obstructive hypertrophic cardiomyopathy (HCM).
ReachMD
Be part of the knowledge.™Reductions in LVOT Gradients, NYHA Class, & NT-proBNP with Cardiac Myosin Inhibitor in HCM
Choose a format
Media formats available:
Facebook Comments